Sonderforschungsbereich/Transregio 130 B-Zellen: Immunität und Autoimmunität

The inhibitory receptor Siglec-G controls the severity of chronic lymphocytic leukemia (2023) Röder B, Fahnenstiel H, Schäfer S, Budeus B, Dampmann M, Eichhorn M, Angermüller S, et al. Journal article Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus (2023) Korn M, Steffensen M, Brandl C, Royzman D, Daniel C, Winkler T, Nitschke L Journal article he role of Fc gamma RIIB expression on B cells for anti-DNA autoantibody development in SLE (2022) Gleußner N, Schneider A, Brey S, Nimmerjahn F, Winkler T Conference contribution B-cell antigen receptor expression and phosphatidylinositol 3-kinase signaling regulate genesis and maintenance of mouse chronic lymphocytic leukemia (2022) Schmid VK, Khadour A, Ahmed N, Brandl C, Nitschke L, Rajewsky K, Jumaa H, Hobeika E Journal article Sialic acids on B cells are crucial for their survival and provide protection against apoptosis (2022) Linder A, Schmidt M, Hitschfel J, Abeln M, Schneider P, Gerardy-Schahn R, Münster-Kühnel AK, Nitschke L Journal article Human CD22-transgenic, primary murine lymphoma challenges immunotherapies in organ-specific tumor microenvironments (2021) Gsottberger F, Brandl C, Wendland K, Petkovic S, Emmerich C, Erber R, Geppert CI, et al. Journal article Cd22 controls germinal center b cell receptor signaling, which influences plasma cell and memory b cell output (2021) Meyer SJ, Steffensen M, Acs A, Weisenburger T, Wadewitz C, Winkler T, Nitschke L Journal article Cullin 3 Is Crucial for Pro-B Cell Proliferation, Interacts with CD22, and Controls CD22 Internalization on B Cells (2020) Meyer SJ, Böser A, Korn M, Koller C, Bertocci B, Reimann L, Warscheid B, Nitschke L Journal article Role of IFN-gamma-activation of distinct tumor and stromal cell populations in colorectal carcinoma pathogenesis (2019) Britzen-Laurent N, Guo W, Langer V, Khoziainova S, Weisenburger T, Winkler T, Straube J, et al. Conference contribution Myc-Driven, Primary Mouse Lymphoma Expressing Human CD22 Are Highly Infiltrated By Syngeneic Immune Cells and Provide a Unique Model to Test CD22-Targeted Therapies (2018) Wagner F, Brandl C, Emmerich C, Mackensen A, Nitschke L, Müller F Conference contribution